🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our toxSYN™ technology consists of a number of linker-payloads. We provide multiple options to maximize efficacy in light of tumor biology. Choose one of our linker-payloads, attach to your antibody and go straight to #ADC product development following positive proof-of-concept

Not only is our industry-leading technology able to significantly level up your ADC pipeline, we can also transform your bispecific offering! We are able to directly convert any off-the-shelf antibody into a bispecific. #drugdevelopment #ADCs #biotech

We will be in San Diego next week for #WorldADC 2024. Anette Sommer will give a presentation on how Synaffix's Platform Technologies enable #ADCs with best-in-class therapeutic index potential. Get in touch to find out how we can revolutionise your pipeline.

Synaffix today announces it has entered into a licensing agreement with Elevation Oncology . The agreement allows Elevation access to Synaffix's #ADC technology platform for the development of its new HER3 ADC program, EO-1022. Full press release linked below.

Today marks #WorldCancerDay, which Synaffix is proud to support. At #Synaffix it is our mission to use our innovative #ADC technology platform to aid the development of best-in-class targeted cancer therapies. #adcs #oncology #UnitedbyUnique

Catch Synaffix Head of R&D Floris van Delft along with other members of the team in London next week for the 15th Annual #WorldADC 3rd- 6th March 2025. Get in touch to arrange a meeting. We hope to see you there! #WorldADC #ADCs #bispecifics

Tomorrow marks #IWD2025, and at Synaffix we are proud to support such an important initiative. Join us on this day as we #AccelerateAction and strive for a world that is diverse, equitable, and inclusive.

Last week Synaffix had the pleasure of hosting a ribbon cutting ceremony to unveil our brand new cutting-edge facility in Oss! With this new facility comes increased and streamlined research capabilities, bolstering our offering as the industry's ADC partner of choice. #ADCs

Catch Synaffix in Chicago for the American Association for Cancer Research (AACR) Annual Meeting 2025, held between April 25-30, 2025! The Synaffix team are delivering two presentations, and the posters are available to view here: synaffix.com/events-media/

The Synaffix team had a fantastic time in Chicago recently for #AACR2025. The event was filled with contributions from leading innovators in the #oncology space. Members of the Synaffix team presented two posters which you can view here: synaffix.com/events-media/

Join Synaffix on June 1, 2025 in showing support for this year's National Cancer Survivors Day. This important initiative is a celebration of those who have survived, offering inspiration, hope, and support for those recently diagnosed and their families. #oncology #cancer

The Synaffix team will be in Incheon, South Korea from June 10-12, 2025 for World ADC Asia 2025. As a Senior Partner of the event, Synaffix is proud to support this conference as it highlights the growing status of Asia in ADC innovation and breakthroughs. #ADCs #biotech